The global pain management drugs market is undergoing a structural pivot, projected to grow from USD 82.29 billion in 2025 to USD 127.65 billion by 2035. According to a comprehensive forecast by Fact.MR, the industry is advancing at a 4.5% CAGR, driven by a dual-force of rising chronic pain prevalence and an urgent clinical shift toward non-opioid, multimodal...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek